How To Deal With Carcinoma In The Colon
One of the most aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The most negative part about the disease is that it is usually detected in it’s late stages where is it very difficult to curb it and treat it.
As the symptoms of neuroendocrine colon cancer take form only in the most advanced stages the rate of survival drops at an alarming rate. Existing tumors are malignant and are usually detected with distant metastases. Surveys show reports reveal that in almost all cases of neuroendocrine cancer ends in death.
Although the possibilities of neuroendocrine carcinoma in colon are extremely unlikely, if one has the misfortune to become affected the patient’s heath becomes much worse than patients who suffer from adenocarcinoma.
Research shows that the end results of this form of cancer stay the same with age, sex or tumor location. However, neuroendocrine colon carcinoma depends on which stage the tumor is in The usual trends have revealed that people in stage 1 and 2 of cancer will generally not experience neuroendocrine colon cancer. On the other hand, in the majority of cases when the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.
Unfortunately, medical science has few techniques to help patients with this cancer. Among the more popular methods that doctors might use is immunohistochemical staining methods. This method helps doctors in dealing with the severity of the neuroendocrine colon cancer and really helps determine the best medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of said tumor with an antibody called A-80 which helps to identify the quantum of neuroendocrine differentiation and the amount of damage caused to the health.
Neuroendocrine colon carcinoma is hard to treat and in a case study in which a number of patients suffered from colon carcinoma underwent examination and, an observation was made that a general rate of survival surrounding this disease was approximately seven months. In a predominant stage these rates drop to less than five months Most of these cases were originally seen as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a poor prognosis and surgery is not always a guaranteed treatment so, even surgery does not even cure the patient. So this makes it important to detect this disease on time and administer the proper treatment.